Screener
Indivior Pharmaceuticals, Inc. INDV Income Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $356M+13.4% | $343M+13.6% | $317M+19.2% | $358M+19.7% | $314M+2.3% | ||
| $51M-38.6% | $50M-3.8% | $40M-9.1% | $67M+39.6% | $83M+25.8% | ||
| $305M+32.6% | $294M+17.6% | $277M+25.3% | $292M+16.8% | $230M-4.6% | ||
| 85.7%+12.4pp | 85.7%+2.9pp | 87.4%+4.3pp | 81.6%-2.0pp | 73.2%-5.3pp | ||
| $5M-84.8% | $12M-42.9% | $16M-27.3% | $21M-32.3% | $33M+50.0% | ||
| $119M-23.2% | $122M-22.8% | $124M-6.8% | $189M+8.0% | $155M+9.2% | ||
| $125M-33.2% | $134M-25.1% | $139M-10.9% | —— | $187M-9.2% | ||
| $180M+319% | $160M+122% | $137M+108% | $81M+76.1% | $43M+22.9% | ||
| 50.6%+36.9pp | 46.6%+22.8pp | 43.2%+18.4pp | 22.6%+7.2pp | 13.7%+2.3pp | ||
| $2M-83.3% | $2M-86.7% | $7M-41.7% | $6M-53.8% | $12M+9.1% | ||
| $182M+392% | $160M+158% | $115M+94.9% | $81M+113% | $37M+23.3% | ||
| $45M+1,000% | $38M-13.6% | $26M+136% | —— | -$5M-163% | ||
| $137M+226% | $122M+578% | $89M+89.4% | $102M+386% | $42M+90.9% | ||
| 38.5%+25.1pp | 35.6%+29.6pp | 28.1%+10.4pp | 28.5%+21.5pp | 13.4%+6.2pp | ||
| $1.12+239% | $0.98+600% | $0.69+81.6% | $0.79+394% | $0.33+106% | ||
| $181M+293% | $162M+119% | $139M+101% | $83M+62.7% | $46M+17.9% | ||
| 50.8%+36.2pp | 47.2%+22.7pp | 43.8%+17.9pp | 23.2%+6.1pp | 14.6%+1.9pp | ||
| $180M+319% | $160M+122% | $137M+108% | $81M+76.1% | $43M+22.9% |
FAQ
- What is Indivior Pharmaceuticals, Inc.'s revenue?
- Indivior Pharmaceuticals, Inc. (INDV) generated $1.4B in revenue over the trailing twelve months, up 16.3% year over year.
- Is Indivior Pharmaceuticals, Inc. profitable?
- Indivior Pharmaceuticals, Inc. reported $450.0M in net income over the trailing twelve months, a 32.8% net margin.
- What are Indivior Pharmaceuticals, Inc.'s profit margins?
- Gross margin is 85.0% and operating margin is 40.6%, with a 32.8% net margin.
- What is Indivior Pharmaceuticals, Inc.'s earnings per share?
- Indivior Pharmaceuticals, Inc.'s diluted EPS over the trailing twelve months is $3.58.
- Where does Indivior Pharmaceuticals, Inc.'s income statement data come from?
- Every line is extracted from Indivior Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
